Cargando…

Linking Individual Natural History to Population Outcomes in Tuberculosis

BACKGROUND: Substantial individual heterogeneity exists in the clinical manifestations and duration of active tuberculosis. We sought to link the individual-level characteristics of tuberculosis disease to observed population-level outcomes. METHODS: We developed an individual-based, stochastic mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvatore, Phillip P, Proaño, Alvaro, Kendall, Emily A, Gilman, Robert H, Dowdy, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853266/
https://www.ncbi.nlm.nih.gov/pubmed/29106638
http://dx.doi.org/10.1093/infdis/jix555
Descripción
Sumario:BACKGROUND: Substantial individual heterogeneity exists in the clinical manifestations and duration of active tuberculosis. We sought to link the individual-level characteristics of tuberculosis disease to observed population-level outcomes. METHODS: We developed an individual-based, stochastic model of tuberculosis disease in a hypothetical cohort of patients with smear-positive tuberculosis. We conceptualized the disease process as consisting of 2 states—progression and recovery—including transitions between the 2. We then used a Bayesian process to calibrate the model to clinical data from the prechemotherapy era, thus identifying the rates of progression and recovery (and probabilities of transition) consistent with observed population-level clinical outcomes. RESULTS: Observed outcomes are consistent with slow rates of disease progression (median doubling time: 84 days, 95% uncertainty range 62–104) and a low, but nonzero, probability of transition from disease progression to recovery (median 16% per year, 95% uncertainty range 11%–21%). Other individual-level dynamics were less influential in determining observed outcomes. CONCLUSIONS: This simplified model identifies individual-level dynamics—including a long doubling time and low probability of immune recovery—that recapitulate population-level clinical outcomes of untreated tuberculosis patients. This framework may facilitate better understanding of the population-level impact of interventions acting at the individual host level.